More than 530 million people worldwide living with diabetes are at risk for developing diabetic retinal disease (DRD), the leading cause of blindness in working-age adults. 1·DRD is a growing epidemic ...
U.S. Animal Health Country Managing Director at Boehringer Ingelheim. "Each year, we invest nearly 12 percent of our sales into researching and developing products that will advance the health of ...
Ingelheim, Germany and Ann Arbor, MI, USA, November 12, 2024 – Boehringer Ingelheim and the Mary Tyler Moore Vision Initiative ... Boehringer Ingelheim is a biopharmaceutical company active in both ...
Boehringer Ingelheim Animal Health is working on first-in-class innovation for the prediction, prevention, and treatment of diseases in animals. For veterinarians, pet owners, producers ...
Animal health is a primary concern among veterinarians, doctors, and public health experts around the world as the health of animals is closely connected to that of humans. This approach of ...
Ingelheim: Boehringer Ingelheim and researchers from the Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard have agreed to collaborate on a project to tackle the urgent ...
An FMD outbreak would be disastrous for Australia’s livestock industry and could wipe out an estimated $80b from the industry over ten years. Head of Animal Health, Boehringer Ingelheim Australia and ...
Boehringer Ingelheim’s weight-loss drug candidate survodutide could also be effective for liver disease metabolic dysfunction-associated steatohepatitis (MASH), if the results of a mid-stage ...
Boehringer Ingelheim says it is on track to launch 25 ... and gastric cancer planned in the second half of this year. Mental health was also put into the spotlight, with Casarosa singling out ...